Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | GILD | BMY | AMGN | VRTX | REGN |
Company | Gilead Sciences Inc | Bristol-Myers Squibb Company | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals |
Price Information | |||||
Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
Open | 66.58 | 49.00 | 270.63 | 404.50 | 906.90 |
High | 67.19 | 49.00 | 274.45 | 406.83 | 915.70 |
Low | 66.37 | 48.55 | 269.65 | 399.37 | 904.41 |
Last | 67.00 | 48.79 | 274.12 | 399.45 | 909.02 |
Change | -0.03 | -0.20 | +0.58 | -5.46 | +1.70 |
% Change | -0.04% | -0.41% | +0.21% | -1.35% | +0.19% |
Volume | 2,521,986 | 4,474,871 | 649,389 | 316,311 | 134,282 |
20-Day Average Volume | 6,180,891 | 10,655,887 | 2,077,246 | 944,147 | 429,282 |
Previous Close | 67.03 | 48.99 | 273.54 | 404.91 | 907.32 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | Yes | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 69.07 | 50.36 | 271.61 | 403.27 | 926.48 |
20-Day Raw Stochastic | 15.43% | 16.47% | 48.23% | 30.80% | 23.15% |
20-Day Relative Strength | 33.42% | 40.67% | 49.29% | 44.56% | 41.11% |
Weighted Alpha | -20.69 | -26.26 | +11.78 | +15.94 | +14.54 |
Today's Opinion | 100% Sell | 88% Sell | 40% Sell | 8% Buy | 24% Buy |
Previous Opinion | 100% Sell | 88% Sell | 40% Sell | 24% Buy | 24% Buy |
Last Month's Opinion | 88% Sell | 8% Sell | 24% Buy | 40% Buy | 80% Buy |
Performance | |||||
5-Days | |||||
%Chg | +0.30% since 04/17/24 | +1.89% since 04/17/24 | +3.81% since 04/17/24 | +1.85% since 04/17/24 | +1.02% since 04/17/24 |
Low | 65.90 on 04/18/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 891.46 on 04/19/24 |
High | 67.68 on 04/23/24 | 49.56 on 04/22/24 | 274.48 on 04/23/24 | 406.86 on 04/23/24 | 920.73 on 04/19/24 |
1-Month | |||||
%Chg | -7.55% since 03/22/24 | -6.13% since 03/22/24 | -0.74% since 03/22/24 | -3.67% since 03/22/24 | -5.87% since 03/22/24 |
Low | 65.90 on 04/18/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 890.43 on 04/16/24 |
High | 73.87 on 03/28/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 421.45 on 04/01/24 | 976.75 on 03/27/24 |
3-Month | |||||
%Chg | -15.59% since 01/24/24 | -2.98% since 01/24/24 | -10.27% since 01/24/24 | -6.36% since 01/24/24 | -3.99% since 01/24/24 |
Low | 65.90 on 04/18/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 890.43 on 04/16/24 |
High | 81.06 on 01/25/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
6-Month | |||||
%Chg | -14.10% since 10/24/23 | -13.14% since 10/24/23 | -0.72% since 10/24/23 | +8.39% since 10/24/23 | +13.20% since 10/24/23 |
Low | 65.90 on 04/18/24 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 341.90 on 11/16/23 | 769.19 on 10/27/23 |
High | 87.86 on 01/19/24 | 56.77 on 10/25/23 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
Key Statistics | |||||
Market Capitalization, $K | 83,457,512 | 99,290,928 | 146,720,288 | 104,652,640 | 99,589,264 |
Shares Outstanding, K | 1,245,077 | 2,026,759 | 536,376 | 258,459 | 109,762 |
Annual Sales | 27,116,000,000 | 45,006,000,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 |
Annual Net Income | 5,665,000,000 | 8,025,000,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 |
Last Quarter Sales | 7,114,000,000 | 11,477,000,000 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 |
Last Quarter Net Income | 1,429,000,000 | 1,762,000,000 | 767,000,000 | 968,800,000 | 1,159,600,000 |
60-Month Beta | 0.19 | 0.39 | 0.58 | 0.35 | 0.11 |
Per-Share Information | |||||
Most Recent Earnings | 1.72 on 02/06/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 |
Latest Earnings Date | 04/25/24 | 04/25/24 | 05/02/24 | 05/06/24 | 05/02/24 |
Most Recent Dividend | 0.770 on 03/14/24 | 0.600 on 04/04/24 | 2.250 on 02/15/24 | N/A | N/A |
Next Ex-Dividends Date | 03/14/24 | 04/04/24 | 05/16/24 | N/A | N/A |
Ratios | |||||
Price/Earnings ttm | 9.96 | 6.55 | 14.58 | 29.76 | 23.95 |